Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Tomasoni

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 30, 2021
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter studyMatteo Pagnesi, Riccardo M Inciardi, Carlo M Lombardi, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Journal of Heart Failure|July 14, 2023
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESCMarco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure|December 9, 2022
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortalityMarianna Adamo, Matteo Pagnesi, Giulia Ghizzoni, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
European Journal of Heart Failure|July 18, 2025
Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTRDaniela Tomasoni, Marianna Adamo, Jörg Hausleiter, et al.
Circulation. Heart Failure|May 15, 2023
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 VaccinationEnrico Ammirati, Laura Lupi, Matteo Palazzini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 30, 2021
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter studyMatteo Pagnesi, Riccardo M Inciardi, Carlo M Lombardi, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Journal of Heart Failure|July 14, 2023
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESCMarco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure|December 9, 2022
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortalityMarianna Adamo, Matteo Pagnesi, Giulia Ghizzoni, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
European Journal of Heart Failure|July 18, 2025
Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTRDaniela Tomasoni, Marianna Adamo, Jörg Hausleiter, et al.
Circulation. Heart Failure|May 15, 2023
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 VaccinationEnrico Ammirati, Laura Lupi, Matteo Palazzini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 21